Eli Lilly & Co. (LLY) Misses Q1 EPS by 7c; Guides Raised
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,144.81 +2.61%
EPS Growth %: +40.3%
Financial Fact:
Revenue: 5.19B
Today's EPS Names:
OCCI, VIVO, PMCB, More
EPS Growth %: +40.3%
Financial Fact:
Revenue: 5.19B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.62, $0.07 worse than the analyst estimate of $1.69. Revenue for the quarter came in at $6.96 billion versus the consensus estimate of $6.84 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2023 EPS of $8.65-$8.85, versus the consensus of $8.45.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- FDA approves Biofrontera's Ameluz for superficial basal cell carcinoma
- Sanofi to transfer 20 medicines and 3 plants to Cheplapharm
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
